Unequal Behaviour between Hydrolysable Functions of Nirmatrelvir under Stress Conditions: Structural and Theoretical Approaches in Support of Preformulation Studies
Nirmatrelvir is an antiviral drug approved for the treatment of COVID-19. The available dosage form consists of tablets marketed under the brand name PAXLOVID<sup>®</sup>. Although knowledge of nirmatrelvir's intrinsic stability may be useful for any potential development of other p...
Uloženo v:
Hlavní autoři: | , , , , , , , , , |
---|---|
Médium: | Kniha |
Vydáno: |
MDPI AG,
2022-08-01T00:00:00Z.
|
Témata: | |
On-line přístup: | Connect to this object online. |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
Internet
Connect to this object online.3rd Floor Main Library
Signatura: |
A1234.567 |
---|---|
Jednotka 1 | Dostupné |